DHEA is the most abundant steroid hormone in your body — and its levels drop by 80-90% between your 20s and 70s. This decline, known as adrenopause, is so consistent that some researchers call DHEA(S) levels a biomarker of biological aging. A 2026 review from Japan, covering 50 years of research, lays out the case: DHEA fights aging through multiple pathways — antioxidant effects, anti-inflammatory action, telomere protection, and direct counterbalance of the stress hormone cortisol. But unlike testosterone or estrogen, DHEA is available over the counter in the United States, which means millions of people take it without knowing if the evidence supports it. Here’s what the science actually says.
⚖️ At a Glance: Pros & Cons
⚠️ We are researchers, not doctors. Nothing on this page is medical advice. DHEA is a hormone, not a vitamin — taking it without blood testing can cause real hormonal side effects. Talk to your doctor before starting. The information below is for education only.
✅ Pros (What the Evidence Supports)
- Strongest benefit: DHEA declines with age predictably and supplementation restores youthful hormone levels — the 2025 meta-analysis of 21 RCTs confirms it effectively raises testosterone and estradiol at doses ≥50 mg/day
- Bone density: Multiple RCTs in older adults show DHEA supplementation improves bone mineral density, particularly in postmenopausal women
- Multi-pathway anti-aging: A 2026 Endocrine Journal review identified six distinct anti-aging mechanisms: antioxidant, anti-inflammatory, telomere protection, p38MAPK inhibition, anti-cortisol effects, and chaperone induction
- Mood and well-being: Several RCTs report improvements in depression scores, energy, and sexual function in older adults with low baseline DHEA-S
❌ Cons (What the Evidence Doesn’t Support or Warns About)
- Biggest limitation: No large-scale longevity or mortality trials — we don’t know if taking DHEA actually extends lifespan, only that it normalizes levels that decline with age
- Hormonal side effects: DHEA converts to testosterone and estrogen — women may experience acne, hair loss, or facial hair; men may experience breast tenderness or prostate concerns at high doses
- J-shaped cardiovascular risk: A 2026 review found both low AND high DHEA levels are associated with higher cardiovascular mortality — suggesting a therapeutic window, not a “more is better” model
- Who should avoid: Anyone with hormone-sensitive cancers (breast, prostate, ovarian), pregnant or breastfeeding women, and people with liver disease — DHEA is a hormone precursor, not a benign supplement
What Is DHEA?
Dehydroepiandrosterone (DHEA) and its sulfate form (DHEA-S) are steroid hormones produced primarily by your adrenal glands. They are the most abundant circulating steroid hormones in the human body — present at concentrations far higher than testosterone, estrogen, or cortisol.
DHEA is a precursor hormone, sometimes called a prohormone. This means your body uses it as raw material to make other hormones: testosterone, estrogen, and androstenedione. But DHEA also has direct effects of its own — it binds to multiple receptors throughout the body, including in the brain, immune cells, blood vessels, and skin.
What makes DHEA uniquely relevant to aging is its predictable decline. Starting around age 25-30, DHEA-S levels drop by approximately 2-3% per year. By age 70, most people have DHEA-S levels 80-90% lower than they did in their 20s. This age-related decline — called adrenopause — happens in both men and women, and it’s so consistent that some researchers have proposed DHEA-S levels as a biomarker of biological aging.
Unlike cortisol (which stays relatively stable with age), DHEA falls dramatically. This means the cortisol-to-DHEA ratio rises with age, shifting the body toward a catabolic, stress-dominant state. Some researchers argue this hormonal shift is one of the core drivers of age-related decline.
How It Works: Six Anti-Aging Mechanisms
A landmark 2026 review by Nawata and colleagues in the Endocrine Journal summarized 50 years of DHEA research and identified six distinct mechanisms through which DHEA exerts anti-aging effects:
1. Antioxidant Protection
DHEA directly scavenges free radicals and protects cell membranes from oxidative damage. It also upregulates the body’s internal antioxidant systems, including glutathione and superoxide dismutase. Oxidative damage accumulates with age and is a hallmark of aging — DHEA appears to slow this accumulation.
2. Anti-Inflammatory Action
DHEA suppresses pro-inflammatory signaling pathways, particularly NF-κB, which drives the chronic low-grade inflammation often called “inflammaging.” A 2026 study found DHEA prevented hippocampal neuroinflammation in animal models — protecting brain cells from inflammatory damage at the source.
3. Telomere Protection
Telomeres are the protective caps on your chromosomes that shorten with age. Shorter telomeres = older biological age. DHEA has been shown to increase telomerase activity (the enzyme that rebuilds telomeres) and slow telomere shortening in multiple cell types. This is one of the most direct mechanisms linking DHEA to slowed biological aging.
4. Anti-Cortisol Effects
Cortisol is your primary stress hormone. While essential for survival, chronically elevated cortisol breaks down muscle, deposits fat (especially visceral fat), thins bones, and impairs immune function. DHEA directly counteracts cortisol at the receptor level — it’s sometimes called an “anti-glucocorticoid” because it blocks cortisol’s catabolic effects. As DHEA falls with age and cortisol stays stable, the balance tips toward chronic tissue breakdown. Supplementation may restore this balance.
5. p38MAPK Inhibition
The p38 MAP kinase pathway is a stress-signaling cascade that becomes overactive with age, driving inflammation and cellular senescence (when cells stop dividing but don’t die — they just sit there, releasing inflammatory signals). DHEA inhibits p38MAPK, potentially reducing this age-related inflammatory signaling.
6. Chaperone Induction
Heat shock proteins and other molecular chaperones help cells maintain proper protein folding. Misfolded proteins accumulate with age and contribute to neurodegenerative diseases. DHEA induces these protective chaperones, helping cells maintain protein quality control.
The Intracrinology Concept
A 2026 review in Cureus highlighted an important concept: intracrinology. This is the local synthesis of active hormones from precursor molecules (like DHEA) within specific tissues, independently of circulating blood levels. Your brain, bones, skin, and immune cells all contain the enzymes needed to convert DHEA into testosterone or estrogen right where they’re needed. When circulating DHEA drops with age, this local production system runs out of raw material — and simply measuring blood hormone levels may not capture the full picture.
The Longevity Connection: What DHEA May Protect Against
🦴 Bone Density and Osteoporosis
Evidence tier: Silver
Multiple RCTs show DHEA supplementation improves bone mineral density in older adults, particularly postmenopausal women. The mechanism appears to be DHEA’s conversion to estradiol and testosterone locally in bone tissue, which stimulates bone-building osteoblasts. A 2025 Australian study of 5,535 women aged 70+ found that low sex steroid concentrations (including DHEA) were associated with a higher incidence of knee and hip replacement for osteoarthritis — suggesting DHEA’s protective role extends to joint health, not just bone density.
🧠 Brain Function and Mood
Evidence tier: Silver
DHEA is concentrated in the brain at levels much higher than in blood, and the brain contains all the enzymes needed to convert DHEA into active neurosteroids. Several RCTs report improvements in depression scores with DHEA supplementation, particularly in older adults with low baseline DHEA-S. The DHEA-S/cortisol ratio has been investigated as a biomarker for depressive symptoms — a 2026 study of 3,005 men found that a lower DHEA-S/cortisol ratio was independently associated with more severe depressive symptoms, separate from testosterone levels.
🫀 Cardiovascular Health
Evidence tier: Bronze
This is where the evidence gets complicated. A 2026 review in Current Cardiology Reports described a J-shaped relationship between DHEA levels and cardiovascular mortality — both very low and very high DHEA are associated with higher risk. This suggests a therapeutic window: restoring age-declined DHEA to youthful levels may be protective, but pushing levels above the normal youthful range could be harmful. A 2026 meta-analysis of 23 prospective cohort studies found that the relationship between sex hormones and cardiovascular outcomes is highly gender-specific, making blanket recommendations difficult.
💪 Muscle Mass and Frailty
Evidence tier: Bronze
DHEA’s anti-cortisol effects and its conversion to testosterone suggest it should protect muscle mass. However, clinical trial results are mixed. Some studies show small improvements in muscle strength and body composition with DHEA supplementation in older adults, while others show no effect. A 2026 study in adults with sarcopenic obesity found that resistance training (not DHEA) was the primary driver of improvements — DHEA changes were modest at best. The 2026 Nawata review notes that DHEA may help prevent frailty through “reverse metabolism” (shifting from catabolic to anabolic state), but the human evidence for muscle is weaker than for bone.
🛡️ Immune Function
Evidence tier: Bronze
DHEA is known to shift immune responses away from the Th2-dominant pattern seen in aging toward a more balanced Th1/Th2 profile. This matters because the age-related immune shift (immunosenescence) contributes to poor vaccine responses and increased infection risk. The 2026 Nawata review specifically notes that DHEA prevents infection and severe illness in older adults, though large RCTs testing this directly are lacking.
👩 Women’s Health: Vaginal Atrophy
Evidence tier: Gold
This is the one area where the evidence is clear and strong. Multiple RCTs and systematic reviews confirm that intravaginal DHEA (6.5 mg/day as a pessary or suppository) effectively treats vulvovaginal atrophy — the thinning, drying, and inflammation of vaginal walls after menopause. A 2026 meta-analysis in Menopause confirmed significant improvements in dyspareunia (painful intercourse), vaginal pH, and tissue health with minimal systemic hormone exposure. A 2026 RCT in Maturitas randomized 172 postmenopausal women to vaginal DHEA vs. estradiol and found both were similarly effective, with DHEA having a favorable safety profile. This is a prescription product (Intrarosa/Prasterone) — not the same as oral DHEA supplements.
Key Studies
| Study | Design | Key Finding |
|---|---|---|
| Nawata et al. (2026) | Comprehensive review (50+ years of research) | Identified six anti-aging mechanisms: antioxidant, anti-inflammatory, telomere protection, p38MAPK inhibition, anti-cortisol effects, chaperone induction. Benefits for atherosclerosis, frailty, sarcopenia, and osteoporosis. |
| DHEA Supplementation Meta-Analysis (2025) | Meta-analysis of 21 RCTs in postmenopausal women | DHEA ≥50 mg/day significantly increased testosterone (+24 ng/dL) and estradiol (+7.9 pg/mL). Women ≥60 years showed greater estradiol increases. Dose-dependent effects confirmed. |
| Androgens & CVD Review (2026) | Systematic review of prospective cohort studies | J-shaped relationship between DHEA and cardiovascular mortality — both low and high levels increase risk. Therapeutic window suggested. |
| Vaginal DHEA Meta-Analysis (2026) | Systematic review of RCTs — intravaginal DHEA | Intravaginal DHEA (6.5 mg/day) significantly improves vaginal atrophy symptoms with minimal systemic absorption. Gold-tier evidence for this indication. |
| DHEA-S/Cortisol Ratio Study (2026) | Cross-sectional analysis of 3,005 men | Lower DHEA-S/cortisol ratio independently associated with more severe depressive symptoms in late-onset hypogonadism, separate from testosterone levels. |
| Osteoarthritis Cohort (2025) | Prospective cohort — 5,535 women aged 70+ | Low circulating sex steroids (including DHEA) associated with higher incidence of knee and hip replacement for osteoarthritis. |
Dosing and Safety
How DHEA Is Taken
DHEA is available over the counter in the United States as a dietary supplement (usually 5-50 mg capsules or tablets). It’s also available by prescription in some forms (particularly vaginal DHEA as Intrarosa/Prasterone). In many other countries — including Canada, the UK, Australia, and most of Europe — DHEA is prescription-only and classified as a controlled substance.
| Population | Dose Range | Evidence |
|---|---|---|
| Older adults (general anti-aging) | 25-50 mg/day oral | Most RCTs use this range. Start at 25 mg and measure blood DHEA-S after 4-6 weeks. Target: mid-range of youthful levels (200-350 μg/dL for men, 150-300 μg/dL for women). |
| Postmenopausal women (bone/mood) | 50 mg/day oral | 2025 meta-analysis confirms 50+ mg significantly raises estradiol and testosterone. Benefits for bone density in multiple RCTs at this dose. |
| Vaginal atrophy (prescription only) | 6.5 mg/day vaginal pessary | Gold-tier evidence. Minimal systemic absorption. Available as Intrarosa/Prasterone (Rx only). |
| Men (general) | 25-50 mg/day oral | Fewer RCTs in men. DHEA can convert to estrogen in men — monitor estradiol levels. Lower doses (25 mg) are safer starting points. |
Safety and Side Effects
| Side Effect | Frequency | Notes |
|---|---|---|
| Acne / oily skin | Common (10-25%) | More common in women, dose-dependent. Usually resolves with dose reduction. |
| Hirsutism (facial/body hair) in women | Moderate (5-15%) | Due to increased testosterone. More common at doses ≥50 mg/day. |
| Hair loss (androgenic alopecia) | Uncommon (3-5%) | In genetically susceptible individuals. Due to DHEA’s conversion to DHT. |
| Breast tenderness / gynecomastia (men) | Uncommon | Due to conversion to estradiol. Monitor estradiol levels in men on DHEA. |
| Irritability / mood changes | Uncommon | Usually transient or resolves with dose adjustment. |
Critical Safety Warning: Hormone-Sensitive Cancers
DHEA converts to testosterone and estradiol in the body. Anyone with a history of hormone-sensitive cancer — including breast cancer, prostate cancer, ovarian cancer, and endometrial cancer — should NOT take DHEA unless specifically prescribed and monitored by an oncologist. The conversion to active sex hormones could theoretically stimulate hormone-sensitive tumor growth.
Blood Testing Is Essential
Unlike most supplements, DHEA requires blood testing. Before starting, measure:
- DHEA-S (sulfate) — this is the storage form, more stable than DHEA itself
- Testosterone (total and free)
- Estradiol (especially important in men and postmenopausal women)
- Cortisol — to assess your DHEA/cortisol balance
Target: Mid-range of youthful levels, NOT supraphysiological levels. The J-shaped cardiovascular risk curve means more is not better.
❓ Common Questions About DHEA
What is DHEA and how does it work?
DHEA is the most abundant steroid hormone in your body, produced by your adrenal glands. It serves as a precursor that your body converts into testosterone and estrogen, but it also has its own direct anti-aging effects — including antioxidant protection, anti-inflammatory action, and blocking the stress hormone cortisol. DHEA levels drop 80-90% between your 20s and 70s, and this decline is linked to many age-related changes.
What does the evidence actually show?
The evidence is strongest for bone density in postmenopausal women (multiple positive RCTs) and for vaginal atrophy when used locally (gold-tier evidence). For mood, sexual function, and skin health, the evidence is promising but comes from smaller studies. A 2025 meta-analysis of 21 RCTs confirmed DHEA effectively raises testosterone and estradiol at doses of 50 mg or more per day. However, there are no large-scale longevity trials showing DHEA extends lifespan.
What’s the right dose?
Most studies use 25-50 mg per day taken orally in the morning (to match the body’s natural rhythm). Start at 25 mg and test your DHEA-S blood levels after 4-6 weeks. The goal is to reach mid-range youthful levels, not to push beyond normal. For postmenopausal women, 50 mg/day has the strongest evidence. The right dose depends entirely on your baseline blood levels — this is not a “one size fits all” supplement.
What are the risks and side effects?
The most common side effects are androgenic: acne, oily skin, and increased facial/body hair in women, caused by DHEA’s conversion to testosterone. These affect 10-25% of users and are dose-dependent. More seriously, DHEA converts to both testosterone and estrogen — which means it could theoretically stimulate hormone-sensitive cancers. A 2026 review found a J-shaped risk curve for cardiovascular disease, meaning both too little and too much DHEA may increase heart risk.
Who should avoid it?
Anyone with a history of breast, prostate, ovarian, or endometrial cancer should avoid DHEA unless specifically prescribed and monitored by an oncologist. Pregnant and breastfeeding women should not take DHEA. People with liver disease should avoid it since DHEA is metabolized in the liver. If you have PCOS (polycystic ovary syndrome), DHEA may worsen androgen excess — consult an endocrinologist first.
The Bottom Line
DHEA sits in an awkward category: it’s a hormone sold as a supplement. The biological rationale for supplementation with age is compelling — levels drop predictably, and restoring them to youthful ranges improves bone density, mood, and possibly immune function. The mechanistic evidence from 50 years of research is strong: DHEA fights aging through at least six distinct pathways.
But the clinical evidence is uneven. For vaginal atrophy, it’s gold-tier — proven in multiple large RCTs. For bone density in postmenopausal women, it’s solid silver. For everything else — muscle preservation, cardiovascular protection, immune enhancement, brain function — the evidence is bronze at best, with studies that are too small, too short, or too inconsistent.
Our verdict: DHEA makes the most sense for people who have documented low DHEA-S levels on blood work and are experiencing age-related symptoms that correlate with that decline — particularly bone loss or mood changes in postmenopausal women. Taking DHEA without blood testing is a gamble. Taking it at high doses without monitoring is reckless.
Who it’s for: Postmenopausal women with low DHEA-S and bone density concerns (strongest evidence). Older adults with low DHEA-S and mood symptoms (moderate evidence). Anyone with confirmed low DHEA-S who wants to restore levels to youthful range under medical supervision.
Who should skip it: Anyone with normal DHEA-S levels (the J-shaped risk curve means more is not better). Men concerned about estrogen elevation. Anyone with cancer history. People unwilling to do baseline and follow-up blood testing.
Medical Disclaimer: This page provides information, not medical advice. DHEA is a hormone that affects multiple body systems. Do not take it without consulting your doctor and getting baseline blood work. The information on this page is for educational purposes only. Full disclaimer →
Sources
- Nawata H, et al. “Anti-aging effects of the adrenal androgens dehydroepiandrosterone and dehydroepiandrosterone sulfate: mechanisms of action and beneficial effects in older people.” Endocrine Journal. 2026. PMID: 41485982
- Meta-analysis of DHEA supplementation in postmenopausal women. “Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials.” Diabetology & Metabolic Syndrome. 2025. PMID: 40616152
- Intracrinology and testosterone pellet therapy review. Cureus. 2026. PMID: 41938679
- Androgens and cardiovascular disease in postmenopausal women. Current Cardiology Reports. 2026. PMID: 42573857
- DHEA-S/cortisol ratio and depressive symptoms in men. The World Journal of Men’s Health. 2026. PMID: 42402869
- Vaginal DHEA for vulvovaginal atrophy — systematic review and meta-analysis. Menopause. 2026. PMID: 41589851
- Vaginal DHEA vs. estradiol RCT for dyspareunia. Maturitas. 2026. PMID: 41903372
- Low sex steroids and osteoarthritis incidence in older women. Maturitas. 2025. PMID: 39693720
- HPA axis dysregulation in older adults with cancer. Journal of Geriatric Oncology. 2026. PMID: 41581430
- Gender-specific sex hormone associations with CVD — meta-analysis. Reviews in Cardiovascular Medicine. 2026. PMID: 42238632